OCT 31
New Users Please Click to Register
Renew or Upgrade your Existing  Account

Hypertension, Dialysis and Clinical Nephrology
VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  eGFR
Slides/audio/handouts:    RRI-2014  :  Brigham-2013  :  ASH-2013  :  ADC-2013 (audio)  :  ASDIN-2013  :  RRI-2013  :  ISHD-HDU-2013  :  Brigham-2012  :  ASH-2012  :  ADC-2012 (audio)  :  NANT-2012  :  ASDIN-2012  :  RPA-2012  :  RRI-2012  :  Brigham-2011  :  ASH-2011  :  ADC-2011  :  NANT-2011  :  ASDIN-2011  :  RPA-2011  :  RRI-2011  :  Fistula First-2010  :  ADC-2010  :  NANT-2010  :  ASDIN-2010  :  RRI-2010  :  RPA-2010  :  Network9,10-2008  : 
TalksbyDate   Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  
cme CE free (CME/CE requires payment)
ISHD Hemodialysis University On-Line (2012-2014)











ISHD Hemodialysis University™ 2013 Shanghai Update (PARTS 5 through 9)   
Flash or IPAD slide/audio
International Society for Hemodialysis
Shanghai, China; April 2013

Part 9
Blood Pressure on Dialysis: Salt volume, RRF and beyond
Madhukar Misra, MD

Anemia in Hemodialysis Patients
Andrew Davenport, MD

Part 8
The Artificial wearable Kidney - Status
Victor Gura, MD

Infection control in the Hemodialysis Unit
Victor Gura, MD

Anemia in Hemodialysis Patients
Hung-Chun Chen, MD

Part 7
When to initiate Dialysis: Early or Late and Why?
Bernard Canaud, MD

Timing and dose of RRT in Acute Kidney Injury
Mark R Marshall, MD

Part 6
Hepatitis in hemodialysis patients
Chiu-Chin Huang, MD

Immune dysfunction in HD patients
Sang Kyung Jo, MD

Part 5
Choice in Dialysis Modality
Xueqing Yu MD

RRT in Acute Kidney Injury: A comparative overview of available therapies
Mark R Marshall, MD



Brigham Nephrology Board Review Course.   
Flash or IPAD slide/audio
Boston, MA; August, 2013

Paraprotein Related Kidney Diseases
Laura M. Dember, MD






Advances in CKD 2014 (PART 7)   
Flash or IPAD slide/audio
Las Vegas, NV; January 2014


Progression of CKD: The role of APOL1 and other recent advances Oral Anticoagulation in Advanced Kidney Disease
Lawrence J. Appel, MD

Smouldering immunologic derangements in ESRD. What are the implications?
Michiel G.H. Betjes, MD

Urgent-Start PD: Patient benefits or financial incentives?
Arshia Ghaffari, MD

Is the Mediterranean diet better than the current approach of protein restriction in pre dialysis CKD?
Martin Kuhlmann, MD


Hypertension, Cardiovascular
Sodium intake and renal outcomes
Very low carb diet good
Processed red meat bad
Both low and high sodium intake bad
Nesiritide for heart failure; bottom line

CKD, Dialysis
Low serum bicarb linked with GFR decline
Troponin in CKD
Postablation recurrence of a. fib
Left atrial appendage occlusion: one side
BP and renal outcomes in VA study of diabetes
Urinary K excretion and risk of HTN
High-dose vitamin D3 no good
Speckle tracking echocardiography
Cannulation technique and fistula survival
Early start of HD neither good nor bad
High serum K vs. low dialysate K
Detecting venous needle dislodgement
Urine phosphorus assay to check beverage P content
Dialysate sodium and BP
Exercise training in CKD meta
Serum testosterone and mortality in CKD
Twice weekly HD may preserve RKF
Aspirin to prevent venous thromboembolism recurrence
Paricalcitol = calcitriol in real life
Increasing dietary fiber lowers uremic toxins
Transplantation better than intensive home HD
Urinary sodium excretion and progression
Novel iron-based P binder
AII blockers no good in HD patients
Angiotensin-neprilysin inhibition better than enalapril for CHF
Twice weekly dialysis in China and QOL

Clinical Nephrology
Diabetic kidney disease consensus conference
Hypomagnesemia in CKD
PPI ups risk of interstitial nephritis
Rituximab good for tough nephrotic syndrome in kids
Light chain deposition disease without proteinuria
Alemtuzumab induction good
Rituximab better than azathioprine for ANCA vasculitis
Serum Mg and heart failure risk in ARIC
Serum osmolarity equations in the elderly
Oral Mg good for elderly women
Occult hepatitis C and glomerular nephropathies
Ultrasonography as good as CT for kidney stones
Increased water intake no good for PKD

This update's selected ASN abstracts

Red cell width distribution and sleep apnea.

Urgent start PD good; Tolvaptan preserves RKF in PD, also lowers LVMI, and increases urine output. Backup AV fistula in PD good; NT-proBNP a good marker; Folic acid therapy improves anemia in PD; PD patients have relatively high PTH, not low; meta-analysis of PD prescriptions in pregnancy.

Clinical Nephrology
Early volume expansion in Shiga toxin HUS; Long-term eculizumab for atypical HUS - stopping therapy, interval extension, hepatotoxicity; 6 vs. 4 months of steroids for nephrotic syndrome in kids; Masked monoclonal membranous-like GN;

Transplant: Cipro for BK virus prophylaxis; IVIG in treatment of BK virus nephropathy; Bisphosphonate meta-analysis; Cinacalcet and delayed graft function; Primary aldo in renal transplantation.
 (Kidney Week 2013...)

News     Hit reload / refresh
RSS  Click on RSS for details of each news story.
Updated: November 18, 2014 (Nov18)
Nov18 Ultrasonography for nephrologists course Jan 10-11, 2015
Nov17 JAMA: New hyperkalemia sorbent effective in reducing hyperkalemia
Nov08 Fiber supplementation lower p-cresol levels
Nov06 Google genomics: storing thousands of genomes in the cloud
Nov04 New portable ultrasound device is disruptive technology.
Oct23 ASN FAQ re Ebola and dialysis
Oct23 CDC guidlines for dialyzing patients with Ebola virus infection
Oct12 Harvard scientists produce insulin-producing pancreatic beta cells on a large scale.
Oct09 Off topic: Levi, Foschi, Hoeistad, and Essen: Abundant heat production...
Oct09 Off topic: One million times the energy density of gasoline.
Oct08 Off topic: The world has just changed, but you don't know it yet.
Sep01 New study confirms benefits of a low carb diet, even when eating some saturated fat.
Sep01 PCSK9 inhibitor arilocumab lowers cholesterol and cardiovascular events
Aug30 Novel heart failure drug shows great promise.
Aug03 Cyanotoxin factsheet from the EPA.
Aug03 Caruaru 1996 microcystin tragedy revisited (NEPHROL thread 2).
Aug03 Caruaru 1996 microcystin tragedy revisited..
Aug02 Cyanobacteria (blue-green algae) in Lake Erie shut down Toledo drinkable water supply.
Aug01 Carbapenem-resistant enterobacter becoming more prevalent.
Jul23 University of Chicago's Dr. Fred Coe's kidney stone website and blog.
General Advances Emphasis
Hypomagnesemia, chronic kidney disease and cardiovascular mortality: Pronounced association but unproven causation
Dr. Dousdampanis and colleagues review the latest evidence regarding low magnesium and CKD, and whether we should treat it; in the October issue of Hemodial Int (more...)

Sailing between Scylla and Charybdis: The high serum K - low dialysate K quandary
Should we use a 3 K bath for most patients? Are 1K and zero K bath's a no-no? Drs. Labriola and Jadoul review the evidence in the Sept/Oct issue of Seminars in Dialysis. (more...)

A stepwise approach for the management of poisoning with extracorporeal treatments Few are using hemoperfusion anymore, and poisoning requires an integrated approach. Dr. Ghannoum and colleagues provide a nice overview in the July/Aug issue of Seminars in Dialysis. (more...)

Hemodialysis for infants, children, and adolescents
Drs. Kaur and Davenport review techniques for performing hemodialysis in children; in the July issue issue of Hemodial Int (more...)

Urgent-start peritoneal dialysis: what are the problems and their solutions? Dr. Mahnensmith discusses this new approach to AKI or acute-on-chronic kidney failure, its advantages and potential problems; in the May/June issue of Seminars in Dialysis. (more...)

Intradialytic hypotension: Frequency, sources of variation and correlation with clinical outcome
Dr. Sands and colleagues delve into large databases to better understand the occurrence and risk factors for intradialytic hypotension; in the April issue of Hemodial Int (more...)

Hemodialysis-associated cardiomyopathy: a newly defined disease entity Drs. McIntyre and Odudu describe their latest results regarding myocardial stunning; in the Mar/Apr issue of Seminars in Dialysis. (more...)

Nonadherence in dialysis patients: prevalence, measurement, outcome, and psychological determinants Dr. Clarke and colleagues review why adherence is so important to outcomes, and methods that have been suggested to improve this problem; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Approach to prophylactic measures for central venous catheter- related infections in hemodialysis: A critical review
Dr. Silva and colleagues go over what we know works, and which treatments are still experimental; in the Jan-Feb issue of Hemodial Int (more...)

Infrequent dialysis: a new paradigm for hemodialysis initiation Dr. Rhee and colleagues present a novel idea; starting out with twice-a-week dialysis in incident patients with substantial residual kidney function, and discuss potential benefits vs. risks. in the Nov/Dec issue of Seminars in Dialysis. (more...)

Is it time for "green" dialysis?
Dr. Agar talks about power, water, and waste disposal; in the October issue of Hemodial Int (more...)

Improving outcomes in patients with lupus and end-stage renal disease Inda-Filho and colleagues talk about neglected areas in the management of ESRD patients with lupus nephritis; in the Sep/Oct issue of Seminars in Dialysis. (more...)

Essential components of an infection prevention program for outpatient hemodialysis centers Hess and Bren write about how to set this up, potential pitfalls, and expected benefits; in the July/Aug issue of Seminars in Dialysis. (more...)

Mycophenolate fetal toxicity and risk evaluation and mitigation strategies, including complying with FDA requirements.
Kim, Rostas, and Gabardi discuss the potential problems of using mycophenolate mofetil in pregnancy; in the June issue of Am J Transplantation (more...)

What nephrologists need to know about vascular access cannulation Dinwiddie, Brouwer, and colleagues give valuable tips regarding cannulation of vascular access; in the May/June issue of Seminars in Dialysis. (more...)

Physical examination: How to examine the arm with arteriovenous fistula
Sousa and colleagues review the various methods and pitfalls; in the April issue of Hemodial Int (more...)

Diagnosis and treatment of peripheral arterial disease in CKD patients Yevzlin and Gimelli describe practical algorithms for managing peripheral arterial disease in CKD patients; in the March/April issue of Seminars in Dialysis. (more...)

When should a patient receive an arteriovenous graft rather than a fistula? Lee and Allon discuss those instances where it may be advantageous to consider AV graft first; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Debate: Peritoneal dialysis should be the first choice for renal replacement therapy in the elderly Bargman vs. Mallappallil and colleagues argue about the benefits of a PD first strategy in this age group; in the Nov/Dec issue of Seminars in Dialysis. (more...)

New insights on molecular mechanisms of renal aging
Schmitt and Melk discuss new knowledge about pathologic vs. physiologic aging in the kidneys; in the November issue of Am J Transplantation (more...)

  SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

  Advances in CKD (Renal Research Institute) (2014) (2013) (2012) (2011) (2010) (2009)
  Kidney Disease in Type 2 Diabetes: Disease Progression and Emerging Therapies
Philip Raskin, MD; Jennifer Marks, MD, Jerry Yee, MD, Mark Molitch, MD. (2011)
  The Brigham Renal Board Review Course: Selected Lectures (2013) -- (2012) -- (2011)
  American Society of Hypertension (2013)   (2012)   (2011)
  Renal Physicians Association (2012) (2011) (2010) (2009)
  American Society for Diagnostic and Interventional Nephrology (ASDIN) (2013) (2012) (2011) (2010) (2009)
  Fistula First (2010)
  Annual Dialysis Conference (audiofiles) (2012)   (2011) (2010) (2009)
  National Association of Nephrology Technologists (NANT) (2012) (2011) (2010) (2009)
  American Society for Nephrology Renal Week (2009) (2008) (2007)
  American Society for Nephrology Board Review Course (2008) (2007)
  American Society for Nephrology Renal Week (audiofiles) (2009) (2008) (2007)
  Preparing for the New Medical Director Responsibilities (Network 9/10 - RPA Special Symposium)



Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or medical professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented on this server.

Copyright statement:
Disclaimer: The reader is responsible for discerning the validity, factuality or implications of information posted here. The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original poster and are in no way representative of or endorsed by the owners or administration of this website. The posts on this website are the opinion of the specific author and are not statements of advice, opinion, or factual information on behalf of the owner or administration of HDCN or Medtext, Inc. This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall hdcn.com or Medtext, Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site. Fair Use Notice: This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes. In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember YOU are responsible for what YOU post on the internet and YOU could be sued by the original copyright holder if you do not honor these rules. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright we may be contacted concerning copyright matters at: Medtext, Inc. 15W560 89th Street Willowbrook, IL 60527 tel: 630-325-3276 email: editor -at sign- hdcn.com If you require a courier address please send a fax or email and we will provide you with the required information. In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein. If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question. It is our strict policy to disable access to accounts of repeat copyright violation offenders. We will also ban the IP address of repeat copyright violators from future posting on this website with or without a registered account. All 3rd party material posted on this website is copyright the respective owners / authors. hdcn.com makes no claim of copyright on such material. For more information please visit: http://www.law.cornell.edu/uscode/17/107.shtml

Published by Medtext, Inc., Willowbrook, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com

96 97 98 99